CARN-AP
Advanced Practice Addictions Nursing
Certification
Exam Prep
208 Practice Questions and Study Guide
Aligned with the Addictions Nursing Certification Board (ANCB)
CARN-AP Examination Blueprint
Section Domain Questions
1 Neurobiology of Addiction and Pharmacotherapeutics Q1 - Q35
2 Substance Use Disorder Assessment and Diagnosis Q36 - Q65
3 Withdrawal Management and Intoxication Q66 - Q100
4 Medication for Addiction Treatment (MAT) Q101 - Q130
5 Psychosocial, Behavioral, and Psychotherapeutic Interventions Q131 - Q160
6 Special Populations and Co-Occurring Disorders Q161 - Q185
7 Ethical, Legal, and Professional Practice Issues Q186 - Q208
TOTAL 208 Questions
Updated 2026/2027 Edition
CARN-AP Exam Prep | 208 Practice Questions | Page 1
,CARN-AP Advanced Practice Addictions Nursing Certification Study Guide & Practice Exam
MAT Act Provisions | Eliminated X-Waiver | Updated CDC Opioid Prescribing Guidelines | New
Pharmacotherapy Approvals
Cognitive Level Distribution: 25% Recall | 50% Application | 25% Analysis
Question Style: 80% Scenario-Based | 20% Direct Recall and Pharmacology/Regulatory Identification
CARN-AP Exam Prep | 208 Practice Questions | Page 2
,CARN-AP Advanced Practice Addictions Nursing Certification Study Guide & Practice Exam
How to Use This Study Guide
This comprehensive study guide contains 208 practice questions specifically designed to mirror the cognitive
complexity, clinical reasoning, and blueprint weighting of the Addictions Nursing Certification Board
(ANCB) CARN-AP examination. Each question is constructed to assess advanced practice-level knowledge
in addictions nursing, including prescriptive authority, pharmacotherapeutic decision-making, integrated
assessment, and regulatory compliance under current federal law. Questions are organized across seven
content domains that correspond to the published examination blueprint, allowing candidates to identify and
remediate specific knowledge gaps systematically.
Each item follows a standardized format: a clinical or recall stem, four response options (A through D) with
one best answer, an explicit correct answer designation, and a 3-to-4 sentence rationale grounded in
neurobiological mechanisms, DSM-5-TR diagnostic criteria, pharmacotherapeutic principles, monitoring
parameters, safety considerations, and current regulatory standards. Distractors are deliberately constructed
from common examination pitfalls, including misapplication of DSM-5-TR severity specifiers, confusion
between intoxication and withdrawal presentations, incorrect interpretation of CIWA-Ar and COWS scoring,
inappropriate MAT agent selection, failure to recognize dangerous withdrawal complications, and conflation
of 42 CFR Part 2 with HIPAA confidentiality requirements.
The 2026/2027 updates integrated throughout this guide reflect the Mainstreaming Addiction Treatment
(MAT) Act provisions, which eliminated the federal X-waiver requirement for buprenorphine prescribing;
the 2022 CDC Clinical Practice Guideline for Prescribing Opioids, which de-emphasized rigid morphine
milligram equivalent (MME) thresholds; expanded naloxone standing-order distribution; and emerging
pharmacotherapy approvals for opioid use disorder, alcohol use disorder, and stimulant use disorder.
Candidates are strongly encouraged to complete each section, review rationales for both correct and incorrect
options, and use domain-level scoring to direct focused remediation before attempting the certification
examination.
CARN-AP Exam Prep | 208 Practice Questions | Page 3
, CARN-AP Advanced Practice Addictions Nursing Certification Study Guide & Practice Exam
Section 1: Neurobiology of Addiction and Pharmacotherapeutics
Neurotransmitters, Reward Pathways, Tolerance, Withdrawal, and Medication for Addiction Treatment (MAT)
foundations
Q1: A 42-year-old patient with severe opioid use disorder asks the CARN-AP why opioids 'feel so
rewarding' despite devastating life consequences. Which neuroanatomical structure is the
PRIMARY final common substrate of natural and drug-induced reward?
A. Hippocampus
B. Ventral tegmental area (VTA) to nucleus accumbens pathway [CORRECT]
C. Locus coeruleus noradrenergic projection
D. Dorsal raphe serotonergic nucleus
Correct Answer: B
Rationale: The mesolimbic dopamine pathway, originating in the ventral tegmental area (VTA) and projecting to
the nucleus accumbens, is the primary final common substrate of reward for both natural reinforcers and addictive
substances. Addictive drugs hijack this circuit by producing dopamine elevations that are larger, faster, and more
sustained than natural rewards, driving pathological reinforcement and craving. The hippocampus modulates
contextual memory, the locus coeruleus mediates withdrawal arousal via noradrenergic hyperactivity, and the dorsal
raphe contributes serotonergic tone that modulates mood rather than serving as the primary reward substrate.
Q2: A patient with alcohol use disorder describes intense cravings triggered by walking past a
favorite bar. This cue-induced craving is mediated by incentive-sensitization theory, which posits
that repeated substance exposure selectively sensitizes which neurochemical process?
A. GABA-A receptor downregulation in the amygdala
B. Dopamine signaling in the nucleus accumbens ('wanting') [CORRECT]
C. Serotonin reuptake inhibition in the prefrontal cortex
D. Glutamate-mediated long-term depression in the thalamus
Correct Answer: B
Rationale: Robinson and Berridge's incentive-sensitization theory distinguishes 'wanting' (incentive motivation,
mediated by mesolimbic dopamine) from 'liking' (hedonic pleasure, mediated by opioid-GABA systems in hedonic
hotspots). Repeated substance exposure sensitizes dopamine-related 'wanting' circuits out of proportion to 'liking,'
explaining why cue-induced cravings intensify even as the pleasurable effects of the drug diminish. This is why the
patient craves the bar cue despite declining euphoria from alcohol.
Q3: An advanced practice nurse is teaching staff about the role of the prefrontal cortex (PFC) in
addiction. Which statement best reflects the current understanding of PFC dysfunction in
moderate-to-severe substance use disorders?
A. The PFC becomes hyperactive, leading to exaggerated inhibitory control and rigid abstinence.
B. PFC hypoactivity weakens executive control, tipping the balance toward striatum-driven automatic
drug-seeking. [CORRECT]
CARN-AP Exam Prep | 208 Practice Questions | Page 4
Advanced Practice Addictions Nursing
Certification
Exam Prep
208 Practice Questions and Study Guide
Aligned with the Addictions Nursing Certification Board (ANCB)
CARN-AP Examination Blueprint
Section Domain Questions
1 Neurobiology of Addiction and Pharmacotherapeutics Q1 - Q35
2 Substance Use Disorder Assessment and Diagnosis Q36 - Q65
3 Withdrawal Management and Intoxication Q66 - Q100
4 Medication for Addiction Treatment (MAT) Q101 - Q130
5 Psychosocial, Behavioral, and Psychotherapeutic Interventions Q131 - Q160
6 Special Populations and Co-Occurring Disorders Q161 - Q185
7 Ethical, Legal, and Professional Practice Issues Q186 - Q208
TOTAL 208 Questions
Updated 2026/2027 Edition
CARN-AP Exam Prep | 208 Practice Questions | Page 1
,CARN-AP Advanced Practice Addictions Nursing Certification Study Guide & Practice Exam
MAT Act Provisions | Eliminated X-Waiver | Updated CDC Opioid Prescribing Guidelines | New
Pharmacotherapy Approvals
Cognitive Level Distribution: 25% Recall | 50% Application | 25% Analysis
Question Style: 80% Scenario-Based | 20% Direct Recall and Pharmacology/Regulatory Identification
CARN-AP Exam Prep | 208 Practice Questions | Page 2
,CARN-AP Advanced Practice Addictions Nursing Certification Study Guide & Practice Exam
How to Use This Study Guide
This comprehensive study guide contains 208 practice questions specifically designed to mirror the cognitive
complexity, clinical reasoning, and blueprint weighting of the Addictions Nursing Certification Board
(ANCB) CARN-AP examination. Each question is constructed to assess advanced practice-level knowledge
in addictions nursing, including prescriptive authority, pharmacotherapeutic decision-making, integrated
assessment, and regulatory compliance under current federal law. Questions are organized across seven
content domains that correspond to the published examination blueprint, allowing candidates to identify and
remediate specific knowledge gaps systematically.
Each item follows a standardized format: a clinical or recall stem, four response options (A through D) with
one best answer, an explicit correct answer designation, and a 3-to-4 sentence rationale grounded in
neurobiological mechanisms, DSM-5-TR diagnostic criteria, pharmacotherapeutic principles, monitoring
parameters, safety considerations, and current regulatory standards. Distractors are deliberately constructed
from common examination pitfalls, including misapplication of DSM-5-TR severity specifiers, confusion
between intoxication and withdrawal presentations, incorrect interpretation of CIWA-Ar and COWS scoring,
inappropriate MAT agent selection, failure to recognize dangerous withdrawal complications, and conflation
of 42 CFR Part 2 with HIPAA confidentiality requirements.
The 2026/2027 updates integrated throughout this guide reflect the Mainstreaming Addiction Treatment
(MAT) Act provisions, which eliminated the federal X-waiver requirement for buprenorphine prescribing;
the 2022 CDC Clinical Practice Guideline for Prescribing Opioids, which de-emphasized rigid morphine
milligram equivalent (MME) thresholds; expanded naloxone standing-order distribution; and emerging
pharmacotherapy approvals for opioid use disorder, alcohol use disorder, and stimulant use disorder.
Candidates are strongly encouraged to complete each section, review rationales for both correct and incorrect
options, and use domain-level scoring to direct focused remediation before attempting the certification
examination.
CARN-AP Exam Prep | 208 Practice Questions | Page 3
, CARN-AP Advanced Practice Addictions Nursing Certification Study Guide & Practice Exam
Section 1: Neurobiology of Addiction and Pharmacotherapeutics
Neurotransmitters, Reward Pathways, Tolerance, Withdrawal, and Medication for Addiction Treatment (MAT)
foundations
Q1: A 42-year-old patient with severe opioid use disorder asks the CARN-AP why opioids 'feel so
rewarding' despite devastating life consequences. Which neuroanatomical structure is the
PRIMARY final common substrate of natural and drug-induced reward?
A. Hippocampus
B. Ventral tegmental area (VTA) to nucleus accumbens pathway [CORRECT]
C. Locus coeruleus noradrenergic projection
D. Dorsal raphe serotonergic nucleus
Correct Answer: B
Rationale: The mesolimbic dopamine pathway, originating in the ventral tegmental area (VTA) and projecting to
the nucleus accumbens, is the primary final common substrate of reward for both natural reinforcers and addictive
substances. Addictive drugs hijack this circuit by producing dopamine elevations that are larger, faster, and more
sustained than natural rewards, driving pathological reinforcement and craving. The hippocampus modulates
contextual memory, the locus coeruleus mediates withdrawal arousal via noradrenergic hyperactivity, and the dorsal
raphe contributes serotonergic tone that modulates mood rather than serving as the primary reward substrate.
Q2: A patient with alcohol use disorder describes intense cravings triggered by walking past a
favorite bar. This cue-induced craving is mediated by incentive-sensitization theory, which posits
that repeated substance exposure selectively sensitizes which neurochemical process?
A. GABA-A receptor downregulation in the amygdala
B. Dopamine signaling in the nucleus accumbens ('wanting') [CORRECT]
C. Serotonin reuptake inhibition in the prefrontal cortex
D. Glutamate-mediated long-term depression in the thalamus
Correct Answer: B
Rationale: Robinson and Berridge's incentive-sensitization theory distinguishes 'wanting' (incentive motivation,
mediated by mesolimbic dopamine) from 'liking' (hedonic pleasure, mediated by opioid-GABA systems in hedonic
hotspots). Repeated substance exposure sensitizes dopamine-related 'wanting' circuits out of proportion to 'liking,'
explaining why cue-induced cravings intensify even as the pleasurable effects of the drug diminish. This is why the
patient craves the bar cue despite declining euphoria from alcohol.
Q3: An advanced practice nurse is teaching staff about the role of the prefrontal cortex (PFC) in
addiction. Which statement best reflects the current understanding of PFC dysfunction in
moderate-to-severe substance use disorders?
A. The PFC becomes hyperactive, leading to exaggerated inhibitory control and rigid abstinence.
B. PFC hypoactivity weakens executive control, tipping the balance toward striatum-driven automatic
drug-seeking. [CORRECT]
CARN-AP Exam Prep | 208 Practice Questions | Page 4
